Clinical Trials · NCT03548987
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 902
- Start date
- Jun 2018
- Locations
- 72 sites, 10 countries
- Primary endpoint
- Change From Randomisation to Week 68 in Body Weight (%)